학술논문
Risk Factors for Meeting Criteria for Switching from Bevacizumab to Aflibercept When Treating Eyes with Diabetic Macular Edema and Visual Acuity of < 20/40
Document Type
Article
Author
Source
In Ophthalmology June 2024
Subject
Language
ISSN
0161-6420